Genetic linkage and association analysis in type 1 von Willebrand disease: Results from the Canadian Type 1 VWD Study

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 4, 2006, Pages 783-792

  James, P D ^a   Paterson, A D ^b   Notley, C ^a   Cameron, C ^a   Hegadorn, C ^a   Tinlin, S ^a   Brown, C ^a   O'Brien, L ^a   Leggo, J ^a   Lilllicrap, David ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

ABO blood group; Association; Linkage; Von Willebrand disease; Von Willebrand factor

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 8C; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BLOOD GROUP ABO SYSTEM; CANADA; CHILD; CODON; CONTROLLED STUDY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC MARKER; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; PATHOGENESIS; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; QUANTITATIVE GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; VON WILLEBRAND DISEASE;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; CANADA; CHILD; CHILD, PRESCHOOL; FAMILY HEALTH; HUMANS; INFANT; INFANT, NEWBORN; LINKAGE (GENETICS); MIDDLE AGED; PHENOTYPE; VARIATION (GENETICS); VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 33644984651     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01860.x     Document Type: Article

References (64)

1. Ruggeri ZM. von Willebrand factor. J Clin Invest 1997; 99: 559-64.
2. Ginsburg D, Handin RI, Bonthron DT, Donlon TA, Bruns GAP, Latt SA, Orkin SH. Human von Willebrand factor (vWF): Isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985; 228: 1401-3.
3. Sadler JE, Shelton-Inloes BB, Sorace JM, Harlan JM, Titani K, Davie EW. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci USA 1985; 82: 6394-8.
4. Verweij CL, Diergaarde PJ, Hart M, Pannekoek H. Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit. EMBO J 1986; 5: 1839-47.
5. Lynch DC, Zimmerman TS, Collins CJ, Brown M, Morin MJ, Ling EH, Livingston DM. Molecular cloning of cDNA for human von Willebrand factor: Authentication by a new method. Cell 1985; 41: 49-56.
6. Sadler JE. A revised classification of von Willebrand disease. Thromb Haemost 1994; 71: 520-5.
7. Nichols WC, Cooney KA, Mohlke KL, Ballew JD, Yang A, Bruck ME, Reddington M, Novak EK, Swank RT, Ginsburg D. von Willebrand disease in the RIIIS/J mouse is caused by a defect outside of the von Willebrand factor gene. Blood 1994; 83: 3225-31.
8. Ellies LG, Ditto D, Levy GG, Wahrenbrock M, Ginsburg D, Varki A, Le DT, Marth JD. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci USA 2002; 99: 10042-7.
9. Mohlke KL, Purkayastha AA, Westrick RJ, Smith PL, Petryniak B, Lowe JB, Ginsburg D. Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase. Cell 1999; 96: 111-120.
10. de Lange M, Snieder H, Ariens RA, Spector TD, Grant PJ. The genetics of haemostasis: A twin study. Lancet 2001; 359: 101-5.
11. Souto JC, Almasy L, Borrell M, Gari M, Martinez E, Mateo J, Stone WH, Blangero J, Fontcuberta J. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 2000; 101: 1546-51.
12. Rosendaal FR, Bovill EG. Heritability of clotting factors and the revival of the prothrombotic state. Lancet 2002; 359: 638-9.
13. Orstavik KH, Magnus P, Reisner H, Berg K, Graham JB, Nance W. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985; 37: 89-101.
14. Vossen CY, Hasstedt SJ, Rosendaal FR, Callas PW, Bauer KA, Broze GJ, Hoogendoorn H, Long GL, Scott BT, Bovill EG. Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. J Thromb Haemost 2004; 2: 242-7.
15. Harvey PJ, Keightley AM, Lam YM, Cameron C, Lillicrap D. A single nucleotide polymorphism at nucleotide -1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF:AG levels. Br J Haematol 2000; 109: 349-53.
16. Keightley AM, Lam YM, Brady JN, Cameron CL, Lillicrap D. Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:IG levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 1999; 93: 4277-83.
17. Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS. Serial studies in von Willebrand's disease: Variability versus 'variants'. Blood 1980; 56: 712-6.
18. Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand's disease: II. Optimal assignment of the heterozygous genotype (diagnosis) by discriminant analysis. Blood 1979; 54: 137-45.
19. Miller CH, Graham JB, Goldin LR, Elston RC. Genetics of classic von Willebrand's disease: I. Phenotypic variation within families. Blood 1979; 54: 117-36.
20. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
21. Souto JC, Almasy L, Soria JM, Buil A, Stone W, Lathrop M, Blangero J, Fontcuberta J. Genome-wide linkage analysis of von Willebrand factor plasma levels: Results from the GAIT project. Thromb Haemost 2003; 89: 468-74.
22. Miller CH, Dilley A, Richardson L, Hooper WC, Evatt BL. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. Am J Hematol 2001; 67: 125-9.
23. Bloom AL. von Willebrand factor: Clinical features of inherited and acquired disorders. Mayo Clin Proc 1991; 66: 743-51.
24. Budde U, Schneppenheim R, Plendl H, Dent J, Ruggeri ZM, Zimmerman TS. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990; 63: 312-5.
25. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
26. O'Brien LA, James PD, Othman M, Berber E, Cameron C, Notley CR, Hegadorn CA, Sutherland JJ, Hough C, Rivard GE, O'Shaunessey D, Lillicrap D. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood 2003; 102: 549-57.
27. Peake IR, Moodie PA, Liddell MB, Sadler JE, Bloom AL. Family studies and prenatal diagnosis in von Willebrand's disease by PCR amplification of a variable repeat DNA sequence within the von Willebrand factor gene. Thromb Haemost 1989; 62: 1478a.
28. Casana P, Martinez F, Aznar JA, Lorenzo JI, Jorquera JI. Practical application of three polymorphic microsatellites in intron 40 of the human von Willebrand factor gene. Haemostasis 1995; 25: 264-71.
29. Olsson ML, Chester MA. Polymorphism and recombination events at the ABO locus: A major challenge for genomic ABO blood grouping strategies. Transfus Med 2001; 11: 295-313.
30. Yip SP. Sequence variation at the human ABO locus. Ann Hum Genet 2002; 66: 1-27.
31. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 1996; 58: 1347-63.
32. Kruglyak L, Lander ES. Faster multipoint linkage analysis using Fourier transforms. J Comput Biol 1998; 5: 1-7.
33. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 2001; 9: 301-6.
34. Lange C, DeMeo D, Silverman EK, Weiss ST, Laird NM. PBAT: Tools for family-based association studies. Am J Hum Genet 2004; 74: 367-9.
35. Weeks DE, Ott J, Lathrop GM. SLINK: A general simulation program for linkage analysis. Am J Hum Genet 1990; 47 (Suppl.): A204.
36. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97-101.
37. Cooney KA, Nichols WC, Bruck ME, Bahou WF, Shapiro AD, Bowie EJW, Gralnick HR, Ginsburg D. The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain. J Clin Invest 1991; 87: 1227-33.
38. Murray EW, Giles AR, Bridge PJ, Peake IR, Lillicrap DP. Cosegregation of von Willebrand factor gene polymorphisms and possible germinal mosaicism in type IIB von Willebrand disease. Blood 1991; 77: 1476-83.
39. Meyer D, Fressinaud E, Gaucher C, Lavergne JM, Hilbert L, Ribba AS, Jorieux S, Mazurier C. Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: From the patient to the gene. INSERM network on molecular abnormalities in von Willebrand disease. Thromb Haemost 1997; 78: 451-6.
40. Inbal A, Seligsohn U, Kornbrot N, Brenner B, Harrison P, Randi AM, Rabinowitz I, Sadler JE. Characterization of three point mutations causing von Willebrand disease type IIA in five unrelated families. Thromb Haemost 1992; 67: 618-22.
41. Fressinaud E, Mazurier C, Meyer D. Molecular genetics of type 2 von Willebrand disease. Int J Hematol 2002; 75: 9-18.
42. Mazurier C. von Willebrand disease masquerading as haemophilia A. Thromb Haemost 1992; 67: 391-6.
43. Zhang ZP, Lindstedt M, Falk G, Blombäck M, Egberg N, Anvret M. Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I. Am J Hum Genet 1992; 51: 850-8.
44. Baronciani L, Cozzi G, Canciani MT, Peyvandi F, Srivastava A, Federici AB, Mannucci PM. Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. Blood Cells Mol Dis 2003; 30: 264-70.
45. Eikenboom JC, Matsushita T, Reitsma PH, Tuley EA, Castaman G, Briet E, Sadler JE. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. Blood 1996; 88: 2433-41.
46. Bodo I, Katsumi A, Tuley EA, Eikenboom JC, Dong Z, Sadler JE. Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: A possible general mechanism for dominant mutations of oligomeric proteins. Blood 2001; 98: 2973-9.
47. Eikenboom JCJ, Reitsma PH, Peerlinck KMJ, Briët E. Recessive inheritance of von Willebrand's disease type I. Lancet 1993; 341: 982-6.
48. Fass DN, Bowie EJ, Owen CA Jr, Zollman PE. Inheritance of porcine von Willbrand's disease: Study of a kindred of over 700 pigs. Blood 1979; 53: 712-9.
49. Mohlke KL, Ginsburg D. von Willebrand disease and quantitative variation in von Willebrand factor. J Lab Clin Med 1997; 130: 252- 61.
50. Sadler JE. New concepts in von Willebrand disease. Annu Rev Med 2005; 56: 173-91.
51. Sadler JE. Von Willebrand disease type 1: A diagnosis in search of a disease. Blood 2003; 101: 2089-93.
52. Sadler JE. Slippery criteria for von Willebrand disease type 1. J Thromb Haemost 2004; 2: 1720-3.
53. Di Paola J, Federici AB, Mannucci PM, Canciani MT, Kritzik M, Kunicki TJ, Nugent D. Low platelet alpha2beta1 levels in type I von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 1999; 93: 3578-82.
54. Kunicki TJ, Federici AB, Salomon DR, Koziol JA, Head SR, Mondala TS, Chismar JD, Baronciani L, Canciani MT, Peake IR. An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees. Blood 2004; 104: 2359-67.
55. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: A multiethnic study. J Pediatr 1993; 123: 893-8.
56. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454-9.
57. Eikenboom CJ, van Marion V, Putter H, Gomez Garcia EB, Peake IR, Goodeve A, Rodeghiero F, Castaman GC, Federici AB, Batlle J, Meyer D, Mazurier C, Goudemand J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethargen S, Pasi J, Hill F. Analysis of cosegregation of type 1 von Willebrands disease phenotype and von Willebrand factor gene haplotypes in the European Multicenter MCMDM-1 VWD Study. Blood 2003; 102: 90a (Abstract).
58. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-7.
59. Souto JC. Genetic studies in complex disease: The case pro linkage studies. J Thromb Haemost 2003; 1: 1676-8.
60. Rosendaal FR. Genetic studies in complex disease: The case pro-association studies. J Thromb Haemost 2003; 1: 1679-80.
61. Castaman G, Eikenboom JC, Bertina RM, Rodeghiero F. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999; 82: 1065-70.
62. De Visser MC, Sandkuijl LA, Lensen RP, Vos HL, Rosendaal FR, Bertina RM. Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci. J Thromb Haemost 2003; 1: 1771-6.
63. Goodeve AC, Walker M, Peake IR, Rodeghiero F, Castaman GC, Federici AB, Batlle J, Mazurier C, Goudemand J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Holmberg L, Lethagen S, Pasi J, Hill F. Contribution of ABO blood group to type 1 von Willebrand disease in patients entered in the multicentre MCMDM-1 VWD Study. Blood 2003; 102: 91a (Abstract).
64. Bowen DJ, Collins PW, Lester W, Cumming AM, Keeney S, Grundy P, Enayat SM, Bolton-Maggs PH, Keeling DM, Khair K, Tait RC, Wilde JT, Pasi KJ, Hill FG. The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: Co-segregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype. Br J Haematol 2005; 128: 830-6.